High-Quality Boldenone Undecylenate Injection

BM Pharmaceuticals is the manufacturer of Boldenone Undecylenate (Equipoise), available in a package containing 50 ampoules at a concentration of 200mg/ml. This compound serves as a prolonged variant of Methandrostenolone, distinct in properties despite sharing a similar chemical structure. Boldenone, a Dianabol derivative devoid of the 17-alpha-methyl group, offers comparable weight and strength gains to Dianabol.

Equipoise, a testosterone derivative with a carbon double bond, exhibits anabolic potency akin to testosterone but with reduced androgenic effects. Although studies indicate Equipoise is less effective than testosterone, it promotes gradual, high-quality muscle growth, enhances strength and appetite, and boosts hematopoiesis, improving oxygen delivery to muscles, appealing to endurance athletes.

Common Equipoise side effects mirror those of typical steroids, encompassing unnatural hair growth, oily skin, prostate issues, voice changes, abnormal hair patterns, water retention, and rare occurrences of abdominal bloating and elevated blood pressure.

For men, the recommended weekly Equipoise dosage ranges from 300 to 600mg, while women should not exceed 50-100mg weekly. Rotating injection sites and potentially splitting doses can help manage irritation and injection volumes. It is crucial to note that Equipoise’s prolonged presence in the body increases detectability, a factor athletes should consider for competitive purposes.